Low margins, losses dog Ringpai as it eyes Hong Kong IPO
The company hopes to become Hong Kong’s first publicly listed pet hospital chain, hoping investors will overlook its weak performance metrics Key Takeaways: Ringpai has filed to list in Hong…
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
The veterinary vaccine producer raised a modest $6.9 million in its New York listing by selling just 3% of its shares, as it diversifies into the household pets market Key…
